Illban Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-07-2024
- Paid Up Capital ₹ 0.45 M
as on 31-07-2024
- Company Age 46 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 31-07-2024
- Revenue 8.33%
(FY 2023)
- Profit 20.40%
(FY 2023)
- Ebitda 27.81%
(FY 2023)
- Net Worth 25.39%
(FY 2023)
- Total Assets 16.96%
(FY 2023)
About Illban Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.45 M.
The company currently has active open charges totaling ₹1.50 Cr.
Valaparambil Thilakan, Sitadevi Velayudhan, and Vimal Thilakan serve as directors at the Company.
- CIN/LLPIN
U24231KL1978PTC002974
- Company No.
002974
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 1978
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Illban Remedies Pvt Ltd offer?
Illban Remedies Pvt Ltd offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Child and Baby Care Products, Baby Care Products.
Who are the key members and board of directors at Illban Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Valaparambil Thilakan  | Managing Director | 16-Sep-1978 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sitadevi Velayudhan | Director | 03-Aug-1988 | Current |
| Vimal Thilakan | Director | 01-Oct-1998 | Current |
Financial Performance of Illban Remedies.
Illban Remedies Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 8.33% increase. The company also saw a substantial improvement in profitability, with a 20.4% increase in profit. The company's net worth Soared by an impressive increase of 25.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Illban Remedies?
In 2023, Illban Remedies had a promoter holding of 82.67% and a public holding of 17.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 21 Jul 2020 | ₹1.08 M | Open |
Uco Bank Creation Date: 05 May 2009 | ₹8.06 M | Open |
Uco Bank Creation Date: 11 Mar 2008 | ₹2.50 M | Open |
How Many Employees Work at Illban Remedies?
Illban Remedies has a workforce of 17 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Illban Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Illban Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
